249420 — Il Dong Pharmaceutical Co Share Price
Last trade - 00:00- KR₩331bn
- KR₩471bn
- KR₩615bn
- 36
- 31
- 45
- 28
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 6.73 | ||
| PEG Ratio (f) | 0.11 | ||
| EPS Growth (f) | 154.05% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.07 | ||
| Price to Tang. Book | 2.64 | ||
| Price to Free Cashflow | 23.4 | ||
| Price to Sales | 0.54 | ||
| EV to EBITDA | 17.48 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.33% | ||
| Return on Equity | -2.77% | ||
| Operating Margin | 0.19% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 561,845.1 | 560,131.63 | 637,714.49 | 600,757.84 | 614,940.88 | 711,000 | 758,000 | 3.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +644.82 | +12.61 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Il Dong Pharmaceutical Co Ltd is a Korea-based company that primarily engages in the manufacture and sale of pharmaceutical products. The Company primarily manufactures and sells products such as active vitamins, antibiotics, anti-ulcer drugs, anti-hypertensive drugs, anti-arteriosclerotic drugs and others. The Company also sells anti-digestive drugs, anti-pulmonary fibrosis drugs, anti-diabetic drugs, anti-peptic ulcer drugs and others. In addition, the Company manufactures and sells health supplements and special nutritional products.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 1st, 2016
- Public Since
- August 31st, 2016
- No. of Shareholders
- 52,999
- No. of Employees
- 1,433
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KSE
- Shares in Issue
- 27,932,366
- Address
- 2, Baumoe-ro 27-gil, Seocho-gu, SEOUL, 06752
- Web
- https://www.ildong.com/
- Phone
- +82 25263114
- Auditors
- Samil Accounting Corp.
Upcoming Events for 249420
Similar to 249420
Aprogen Biologics
Korea Exchange - KSE
Boryung
Korea Exchange - KSE
Bukwang Pharm Co
Korea Exchange - KSE
Chong Kun Dang Pharmaceutical
Korea Exchange - KSE
CKD Bio
Korea Exchange - KSE
FAQ
As of Today at 21:14 UTC, shares in Il Dong Pharmaceutical Co are trading at KR₩11,930. This share price information is delayed by 15 minutes.
Shares in Il Dong Pharmaceutical Co last closed at KR₩11,930 and the price had moved by -21.37% over the past 365 days. In terms of relative price strength the Il Dong Pharmaceutical Co share price has underperformed the FTSE Developed Asia Pacific Index by -20.47% over the past year.
The overall consensus recommendation for Il Dong Pharmaceutical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreIl Dong Pharmaceutical Co does not currently pay a dividend.
Il Dong Pharmaceutical Co does not currently pay a dividend.
Il Dong Pharmaceutical Co does not currently pay a dividend.
To buy shares in Il Dong Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩11,930, shares in Il Dong Pharmaceutical Co had a market capitalisation of KR₩331bn.
Here are the trading details for Il Dong Pharmaceutical Co:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 249420
Based on an overall assessment of its quality, value and momentum Il Dong Pharmaceutical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Il Dong Pharmaceutical Co is KR₩50,338. That is 321.94% above the last closing price of KR₩11,930.
Analysts covering Il Dong Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of KR₩1,705 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Il Dong Pharmaceutical Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -7.26%.
As of the last closing price of KR₩11,930, shares in Il Dong Pharmaceutical Co were trading -6.5% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Il Dong Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 6.73. The shares last closed at KR₩11,930.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Il Dong Pharmaceutical Co's directors